Back
BCE Vs. NovoCure Industry Stock Comparison
Sell
16
BCE
BCE
Last Price:
26.86
Seasonality Move:
2.31%
Buy
77
NVCR
NovoCure
Last Price:
29.28
Seasonality Move:
2.04%
Sell
16
BCE (BCE)
is a Sell
Is BCE a Buy, Sell or Hold?
- The current BCE [BCE] share price is $27.31. The Score for BCE is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- BCE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
77
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $30.51. The Score for NVCR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCE Stock Price Chart
NVCR Stock Price Chart
BCE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.17 | Sell |
Relative Strength Index (14 RSI): | 33.54 | Sell |
Chaikin Money Flow: | 1092131 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.34 - 30.12) | Sell |
Bollinger Bands (100): | (29.84 - 35.6) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.24 | Buy |
Relative Strength Index (14 RSI): | 84.56 | Buy |
Chaikin Money Flow: | -690353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.69 - 22.01) | Buy |
Bollinger Bands (100): | (15.44 - 20.28) | Buy |
BCE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.94 | Buy |
20-day SMA: | 27.37 | Sell |
50-day SMA: | 31 | Sell |
200-day SMA: | 33.33 | Sell |
8-day EMA: | 27.1 | Buy |
20-day EMA: | 27.91 | Sell |
50-day EMA: | 30.08 | Sell |
200-day EMA: | 33.68 | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.45 | Buy |
20-day SMA: | 18.85 | Buy |
50-day SMA: | 17.12 | Buy |
200-day SMA: | 17.34 | Buy |
8-day EMA: | 23.1 | Buy |
20-day EMA: | 19.92 | Buy |
50-day EMA: | 18.23 | Buy |
200-day EMA: | 19.07 | Buy |
BCE Earnings Growth & BCE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.07 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.32 per share.
BCE Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |